MedTrace Logo

Patients Satisfaction With the Outcomes of Expensive Cytotoxic Agents

NCT02649725 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1800

Last updated 2016-05-03

No results posted yet for this study

Summary

The purpose of this study is to determine whether there is positive (beneficial) impact of expensive cytotoxic agents on the cancer patients. It is a questionnaire based study that will be filled by the cancer patients without obligations.

Conditions

  • Patient's Satisfaction

Interventions

BEHAVIORAL

patient's satisfaction

Questionnaire based measurement.

Sponsors & Collaborators

  • International Medical Center of Egypt.

    collaborator UNKNOWN

  • Metghamr Cancer Center.

    collaborator UNKNOWN

  • Benha University

    collaborator OTHER

  • Misr University for Science and Technology

    collaborator OTHER

  • Kuwait Cancer Control Center

    collaborator OTHER

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Noha S Elbaghdady, Specialis · Misr University for Science and Technology

Eligibility

Min Age
17 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-11-30
Completion
2019-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02649725 on ClinicalTrials.gov